Category: Faculty News

Welcoming New Faculty: Cullen Carter, MD and Chaitan Narsule, MD

August 3rd, 2015


Cullen Carter, MD
Carter_Cullen Attending Surgeon, Section of Minimally Invasive and Weight Loss Surgery, Boston Medical Center
Assistant Professor of Surgery,
Boston University School of Medicine

Dr. Carter received his medical degree from University of Virginia School of Medicine in Charlottesville, VA. He completed his residency in General Surgery at Brigham and Women’s Hospital/Harvard Medical School; a fellowship in Surgical Critical Care also at BWH; and a fellowship in Minimally Invasive Surgery at Wake Forest University Baptist Medical Center. He is board certified by the American Board of Surgery in General Surgery and Surgical Critical Care.

His clinical and research interests include general surgery, bariatric surgery, hernia repair, biliary disease, upper GI surgery, surgical education and outcomes in bariatric surgery

 

 

Narsule_ChaitanChaitan Narsule, MD
Attending Surgeon, Sections of Acute Care and Trauma Surgery and Surgical Critical Care, Boston Medical Center
Assistant Professor of Surgery,
Boston University School of Medicine

Dr. Narsule received his medical degree from Robert Wood Johnson Medical School (UMDNJ) in Piscataway, NJ. He completed a residency in General Surgery at Rhode Island Hospital & Warren Alpert Medical School of Brown University in Providence, RI. Following a year of private practice as a general surgeon, he pursued clinical and research fellowships in thoracic surgery at BMC and Tufts University School of Medicine, prior to returning to BMC for a fellowship in surgical critical care. He is board certified by the American Board of Surgery in General Surgery and Surgical Critical Care.

His clinical and research interests include surgical education, thoracic trauma, minimally invasive surgery and the management of multi-system organ failure.

Dr. Alik Farber Promoted to Professor of Surgery and Radiology

April 9th, 2015

Alik-FarberDr. Alik Farber, Chief, Division of Vascular and Endovascular Surgery at Boston Medical Center (BMC) has been promoted to Professor of Surgery and Radiology at Boston University School of Medicine (BUSM).

Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital; a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center; and an endovascular surgery fellowship at the Southern Illinois School of Medicine.

In addition to his role as Division Chief of Vascular and Endovascular Surgery, Dr. Farber is also Medical Director of BMC’s Catheterization and Angiography Laboratories and Co-Director of BMC’s Vascular Non-invasive Laboratory as well as Associate Chair for Clinical Operations in the Department of Surgery. He is a fellow in the American College of Surgeons and is a member of the American Board of Surgery. He is a member of many national and regional medical and surgical societies, including the Society for Vascular Surgery, where he was elected to distinguished fellow status in 2013, the Society of University Surgeons, the Western Vascular Surgery Society, the New England Society for Vascular Surgery, the International Society for Endovascular Surgery, and the Society for Clinical Vascular Surgery.

Dr. Farber has served as a principal investigator in a number of clinical trials and is currently a National Co-Chair of the BEST-CLI Trial (Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia), a $25 million grant awarded by the National Institutes of Health (NIH), to conduct a four-year, randomized clinical trial comparing traditional bypass surgery with the less invasive alternative of endovascular treatment for patients with critical limb ischemia (CLI).

He has written and published many articles about vascular and endovascular surgery, has served as a moderator for various vascular meetings, and developed a formal education program in vascular surgery while at Cedar-Sinai Medical Center in Los Angeles, CA, which resulted in the Golden Apple Teaching Award for teaching and mentoring residents. Since his arrival at BMC, Dr. Farber has made it his goal and mission to foster continued clinical excellence and academic productivity. He is currently the director of a fourth year medical school elective (BMC Surgery Bootcamp) which is designed to prepare medical students who are going into surgical internship.

Dr. Tony Godfrey Featured in DeGregorio Family Foundation Video

September 23rd, 2014

Tony Godfrey, PhD, Associate Chair of Research in the Department of Surgery, was awarded a two-year, $225,000 grant from the DeGregorio Family Foundation for Gastric and Esophageal Cancer Research & Education. Godfrey, who is also an Associate Professor of Surgery at BUSM, will use the funding to study Barrett’s Esophagus (BE). People with BE are at increased risk for a type of cancer called esophageal adenocarcinoma.

He was recently featured in a DeGregorio Family Foundation video, “Turning Fact Into Fiction: Stomach and Esophageal Cancer Research.”

 

Department of Surgery Seeking Faculty Member in the Section of Minimally Invasive and Weight Loss Surgery

September 15th, 2014

Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) Department of Surgery seeking a new attending and surgery faculty member in the Section of Minimally Invasive and Weight Loss Surgery.

BMC is a 496-bed academic medical center located in Boston’s historic South End. BMC provides a full range of pediatric and adult care services, from primary care and family medicine to advanced specialty care. Emphasizing community-based care, BMC is committed to providing consistently excellent and accessible health services to all—and is the largest safety-net hospital in New England.

BMC is the principal teaching affiliate of Boston University School of Medicine (BUSM). BUSM is highly ranked and committed to urban and international health and has recognized leader in groundbreaking medical research.

The Section of Minimally Invasive and Weight Loss Surgery is a high volume service at BMC and provides non-surgical as well as surgical options for obesity such as bariatric surgery or weight loss surgery, gastric bypass, lap band and gastric sleeve surgery as well as minimally invasive/laparoscopic general surgery services. Our surgeons have performed thousands of successful operations and our Bariatric Surgical Program is recognized as a Center of Excellence by the American College of Surgeons.

We ask that candidates who wish to be considered send a CV and cover letter describing the experiences that qualify them for our position. Please send all materials directly to: Gerard Doherty, MD, Utley Professor and Chair of Surgery, Boston University School of Medicine and Surgeon-in-Chief, Boston Medical Center via email to gerard.doherty@bmc.org. Please include “Minimally Invasive Surgery Position” in the subject line.

 

Boston University and Boston Medical Center are equal opportunity employers, committed to their common mission of improving the health of Boston’s residents while adhering to the highest standards of academic medicine.

BMC and BUSM are affirmative action/equal employment employers.
Women and minorities are encouraged to apply.

Department of Surgery Seeking Faculty Member in the Section of Acute Care & Trauma Surgery

September 15th, 2014

Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) Department of Surgery are seeking a new attending and surgery faculty member in the Section of Acute Care & Trauma Surgery/Surgical Critical Care.

BMC is a 496-bed academic medical center located in Boston’s historic South End. BMC provides a full range of pediatric and adult care services, from primary care and family medicine to advanced specialty care. Emphasizing community-based care, BMC is committed to providing consistently excellent and accessible health services to all—and is the largest safety-net hospital in New England.

BMC is the principal teaching affiliate of Boston University School of Medicine (BUSM). BUSM is highly ranked and committed to urban and international health and has recognized leader in groundbreaking medical research.

Boston Medical Center includes expertise in both adult and pediatric trauma and has over 2,000 trauma admissions per year.  BMC is the largest and busiest provider of trauma and emergency services in New England. It is the longest continuously verified Level I trauma program in the City of Boston and has earned the reputation of one of the country’s finest programs as one of several Centers of Excellence at Boston Medical Center.

We ask that candidates who wish to be considered send a CV and cover letter describing the experiences that qualify them for our position. The successful candidate will be ABS board eligible or certified in Surgery and Surgical Critical Care. Please send all materials directly to: Gerard Doherty, MD, Utley Professor and Chair of Surgery, Boston University School of Medicine and Surgeon-in-Chief, Boston Medical Center via email to gerard.doherty@bmc.org. Please include “Acute Care & Trauma Surgery Position” in the subject line.

Boston University and Boston Medical Center are equal opportunity employers, committed to their common mission of improving the health of Boston’s residents while adhering to the highest standards of academic medicine.

BMC and BUSM are affirmative action/equal employment employers.
Women and minorities are encourage to apply.

Welcoming New Faculty: Angela Kuhnen, MD

August 15th, 2014

Kuhnen_Angela_2-5x3-5

Angela Kuhnen, MD, is a graduate of Yale University in New Haven, CT, and received her medical degree from New York University in New York, NY. She completed her residency in General Surgery at Massachusetts General Hospital in Boston, MA and a Fellowship in Colorectal Surgery at Lahey Clinic in Burlington, MA. She is board certified by the American Board of Surgery.

Her clinical and research interests include Anorectal Disease, Colon and Rectal Cancer, Diverticulitis, Inflammatory Bowel Disease and Surgical Outcomes.

Welcoming New Faculty: Jeffrey J. Siracuse, MD, RPVI

July 8th, 2014

Siracuse_JeffreyJeffrey J. Siracuse, MD, RPVI, Attending Surgeon, Division of Vascular and Endovascular Surgery, Boston Medical Center and Assistant Professor of Surgery and Radiology, Boston University School of Medicine, received his medical degree from New York Medical College in Valhalla, NY. He completed his residency in General Surgery at Beth Israel Deaconess Medical Center/Harvard Medical School, research fellowship in the Harvard-Longwood Vascular Research Training Program,  and his clinical Fellowship in Vascular and Endovascular Surgery at New York-Presbyterian Hospital/Columbia University College of Physicians Surgeons and Weill Cornell Medical College. He is board certified by the American Board of Surgery.

His research and clinical interests include minimally invasive and open treatment of aortic aneurysms, critical limb ischemia, cerebrovascular disease, dialysis access, thoracic outlet syndrome, and venous disease.

Dr. David McAneny, Vice Chair, Department of Surgery featured in Reuters Health discussing BMC’s ICOUGH Program

June 24th, 2014

A Risk-Stratified, Mandatory Prophylaxis Protocol Reduces Postop VTEs

By James E. Barone MD

June 12, 2014

NEW YORK (Reuters Health) – A protocol combining mandatory estimation of risk and prophylaxis orders significantly reduced the incidence of venous thromboembolic events (VTEs) at Boston University and Boston Medical Center, researchers there report.

They found an 84% decrease in the rate of deep venous thrombosis (DVT) – from 1.9% to 0.3% – while the incidence of pulmonary embolism (PE) dropped 55%, from 1.1% to 0.5% (p<0.01 for both).

Senior author Dr. David McAneny spoke with Reuters Health by phone and said, “We were gratified by the improved outcomes after the implementation of our programs.”

The before-and-after study was prompted by the authors’ recognition that their hospital had a high rate of VTE compared to other institutions participating in the National Surgical Quality Improvement Program (NSQIP).

Dr. Peter K. Henke, a professor of surgery and Associate Chair of Research at the University of Michigan, has studied VTE extensively. He said the paper is a “solid contribution to the literature, particularly addressing a high VTE rate at their institution and approaching this in a systematic manner with marked improvement.”

Prior to developing the VTE prevention strategy, no formal prophylaxis guidelines were in place.

The team adopted the Caprini VTE risk stratification method for all general and vascular surgery patients and developed standardized prophylaxis regimens-including drugs, mechanical devices, and ambulation orders-linked to the risk scores.

“The inter-rater reliability of Caprini scoring has been good,” said Dr. McAneny. “In addition to surgery residents, our physician assistants are an important part of maintaining consistent practices.”

Their electronic medical record was modified to require completion of both the risk score and the orders for prophylaxis.

Heparin and mechanical compression were optional for the lowest-risk patients, who were walked frequently. Low-risk patients were treated with either heparin (low dose unfractionated or low molecular weight) or compression boots, and those scored as moderate-risk got both heparin and boots.

High- and highest-risk patients were to receive extended prophylaxis of boots and heparin for seven to 10 days or 30 days, respectively, continuing if necessary after hospital discharge.

At the University of Michigan, “We use the Caprini scoring system and have mandatory risk assessment,” said Dr. Henke. His group typically administers 30-day prophylaxis only for oncology patients and those with inflammatory bowel disease.

The Boston paper, published online in the Journal of the American College of Surgeons, said the prophylaxis order mandate could be overridden by a physician, but the reason had to be documented in an automatic drop-down menu.

After the prophylaxis program began, recommended prophylaxis in the 749 low- and moderate risk-patients was given 100% of the time. Of the 99 high-risk patients, 89% received appropriate prophylaxis as did 10 (77%) of the 13 patients in the highest risk group. All protocol deviations were documented in the electronic record.

Dr. Henke, who was not an author of the study, wondered about patients who received prophylaxis but did not benefit. He said, “This is often a neglected part of aggressive VTE prophylaxis. Anticoagulants do have bleeding risks, and at the very least, a significant monetary cost.”

Dr. McAneny’s group is now analyzing failures of the protocol. He said, “We are investigating patients who developed VTEs despite the protocol, questioning if those events were a function of improper scoring, withholding recommended prophylaxis, or some other reason.”

Before the protocol was adopted, audits of nursing practice showed that only 19.6% of 250 patients were out of bed at the time of the visit vs. 69.1% after the intervention (p<0.001).

Other NSQIP hospitals of over 500 beds during the years studied had annual rates of 0.8% for DVT and 0.4% for PE.

Using a risk-adjusted NSQIP data for the authors’ hospital, the ratio of observed to expected VTE was 3.41 prior to instituting the program, and steadily decreased to an odds ratio of 0.94 (p<0.05).

“It will be difficult to get the rate of VTE to zero because the risks of bleeding from anticoagulation sometimes outweigh the risks of VTE so that prophylaxis cannot be administered,” said Dr. McAneny also noting that certain patients will develop VTEs despite appropriate prophylaxis.

He mentioned several important factors in the success of their program such as its standardization, buy-in by the surgeons-they are all competitive people and none wants to be on the wrong side of the outcomes curve, a user-friendly system with check-box format, mandated VTE hazard scoring and prophylaxis selection or declination, electronic reminders, and regular monitoring and feedback of data.

SOURCE: http://bit.ly/1j7DXOq

J Am Coll Surg 2014.

Nilton Medina, MD, Awarded George H. Kaye Alumni Award for Outstanding Service to Others

May 15th, 2014

Nilton-Medina-MDNilton Medina, MD, Attending Surgeon, Division of Plastic and Reconstructive Surgery, Boston Medical Center and Associate Professor of Surgery, Boston University School of Medicine,was awarded the very first George H. Kaye Alumni Award for Outstanding Service to Others from the Biomedical Science Careers Program (BSCP) at their annual Evening of Hope event.

The award was established in honor of George H. Kaye who was a founding member of BSCP and worked with others to create an organization that would provide students of every race, ethnic background, gender, and financial status with encouragement, support, and guidance needed for the successful pursuit of biomedical science and other science-related careers. 

Dr. Medina first met Mr. Kaye at a BSCP Conference in 1996 as a college student. He was a recipient of a Hope Scholarship in 1998, and has given back to BSCP as a Student Advisor for the last decade. 

About the Biomedical Science Careers Program (BSCP)
The Biomedical Science Careers Program (BSCP), founded in 1991, was incorporated as a not-for-profit organization in 1994. BSCP’s first student conference took place in March 1992 and was attended by 300 high school, college, medical and graduate minority students. Since its inception, more than 10,000 minority students and over 1,100 underrepresented postdoctoral trainees and junior faculty members have participated in BSCP programs. The founding sponsors of the Biomedical Science Careers Program are the Harvard Medical School Minority Faculty Development Program, the New England Board of Higher Education and the Massachusetts Medical Society.

Boston Doctors Reveal Lessons Learned in Marathon Attack

March 21st, 2014

 

http://www.necn.com/03/20/14/Boston-doctors-reveal-lessons-learned-in/landing.html?blockID=864098&feedID=11110